Clinical Trials Browser

Observational × Triple Negative Breast Neoplasms × 1 year × Clear all

NCT04314401 2026-03-18

National Cancer Institute "Cancer Moonshot Biobank"

BreastDermatologicGastrointestinalGenitourinaryGynecologicOther hematologic neoplasmPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Melanoma, Multiple Myeloma, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT05742269 2026-03-13

MIMIR-mTNBC

Triple Negative Breast Neoplasms

NCT07084571 2026-03-12

FORTITUDE

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06709651 2026-03-04

MINA

Triple Negative Breast Neoplasms

NCT07211178 2026-03-04

GEMINI Breast

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT07421479 2026-02-19

PDO-Mercurial

Active not recruiting

Triple Negative Breast Neoplasms

NCT04981119 2026-02-13

BASECAMP-1

BreastGastrointestinalGenitourinaryGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT05914961 2026-02-12

Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer

Triple Negative Breast Neoplasms

NCT05115474 2026-02-09

Study of Screening Brain MRIs in Stage IV Breast Cancer

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07327489 2026-01-08

ELEPHAS-05

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Melanoma, Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06774027 2025-12-18

ENCORE

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04438681 2025-12-04

INSTIGO

Active not recruiting

Triple Negative Breast Neoplasms

NCT07260188 2025-12-03

PDO-Neo01

Triple Negative Breast Neoplasms

NCT07246759 2025-11-24

NEUTROFLOW

Not yet recruiting

BreastDermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT03586297 2025-10-14

Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer

Triple Negative Breast Neoplasms

NCT07211451 2025-10-08

Axillary Nodal Burden in HER2+ and TNBC

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06087120 2025-09-23

BRAVA

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05404321 2025-09-22

TRIPLEX

Triple Negative Breast Neoplasms

NCT03165487 2025-08-22

Comparison of the Breast Tumor Microenvironment

Active not recruiting

Triple Negative Breast Neoplasms

NCT05435352 2025-07-30

PEAR-TNBC

Triple Negative Breast Neoplasms

NCT07073755 2025-07-18

Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06885424 2025-07-15

DESCENT-1

Enrolling by invitation

BreastGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Kidney Neoplasms, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT05396612 2025-07-08

Role of the Immune Environment in Response to Therapy in Breast Cancer

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05891197 2025-07-01

START

BreastGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Recurrence, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT07018427 2025-06-12

Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06991790 2025-05-28

Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration

Triple Negative Breast Neoplasms

NCT06965361 2025-05-16

TIL; PD1; PDL1

Triple Negative Breast Neoplasms

NCT05877859 2025-05-14

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06476119 2025-04-23

OPTImaL

Breast Neoplasms, Triple Negative Breast Neoplasms